← Evidence map

ReviewMolecular biotechnology2021

Advances in Pathophysiology of Triple-Negative Breast Cancer: The Potential of lncRNAs for Clinical Diagnosis, Treatment, and Prognostic Monitoring.

Yangkun Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34245439